Furthermore, a recent clinical study demonstrated that hesperidin (structurally related to hesperetin) improves hepatic steatosis, inflammation, and fibrosis, most likely via modulation of the NF-kB pathway [204]. This evidence concerns the gene NFKB1 and fatty liver disease.